Assessing Sarcopenia, Presarcopenia, and Malnutrition in Axial Spondyloarthritis: Insights from a Spanish Cohort
Nutrients · 2025
DOI: 10.3390/nu17061019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Laura Berbel-Arcobé und 5 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Department, Hospital Universitari de Bellvitge-IDIBELL, Carrer de la Feixa Llarga S/N, L'Hospitalet de Llobregat, 08907 Barcelona, Spain. Hauptthemen laut MEDLINE: Sarcopenia, Malnutrition, Axial Spondyloarthritis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Mangelernährung
Abstract (Originalsprache)
Background/Objectives: Sarcopenia, defined by a loss of muscle mass, strength, and function, is a potential comorbidity in axial spondyloarthritis (axSpA). Its prevalence, along with malnutrition, remains unclear.
Methods
This cross-sectional study assessed sarcopenia (using the European Working Group on Sarcopenia in Older People (EWGSOP-2) criteria), presarcopenia, and malnutrition (using the Global Leadership Initiative on Malnutrition (GLIM) criteria) in a Spanish axSpA cohort. We included 94 patients aged ≥ 50 years. Sarcopenia was evaluated using the SARC-F questionnaire and by measuring muscle strength, mass, and performance. Presarcopenia was defined as low muscle mass alone. Malnutrition was assessed using body mass index (BMI) and fat-free mass index (FFMI).
Results
The prevalence of sarcopenia, presarcopenia, and malnutrition was 3.2%, 23.4%, and 10.6%, respectively. Sarcopenia correlated with worse functionality and quality of life (Bath Ankylosing Spondylitis Functional Index (BASFI) 7.6 ± 1.2 vs. 3.6 ± 2.5, p = 0.02; ASAS Health Index (ASAS-HI) 11 ± 2 vs. 5.6 ± 3.7, p = 0.03). Presarcopenia was linked to a lower BMI (24.7 ± 4.1 vs. 29.1 ± 4.2, p < 0.01), FFMI (16.1 ± 2 vs. 19.6 ± 2.6, p < 0.01), and reduced biologic treatment use (31.8% vs. 61.1%, p = 0.03). Malnourished patients had lower muscle mass (5.14 ± 0.73 vs. 6.23 ± 0.96, p < 0.01). SARC-F showed 100% sensitivity and 75.8% specificity for sarcopenia detection.
Conclusions
Despite low sarcopenia prevalence, presarcopenia and malnutrition are frequent, highlighting the need for early detection in axSpA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rheumatology Department, Hospital Universitari de Bellvitge-IDIBELL, Carrer de la Feixa Llarga S/N, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
ORCID-Profile: Laura Berbel-Arcobé, Diego Benavent, Joan M Nolla
Zitieren
APA
Berbel-Arcobé, L., Benavent, D., Valencia-Muntalà, L., Gómez-Vaquero, C., Juanola, X., & Nolla, J. M. (2025). Assessing Sarcopenia, Presarcopenia, and Malnutrition in Axial Spondyloarthritis: Insights from a Spanish Cohort. Nutrients. https://doi.org/10.3390/nu17061019
Vancouver
Berbel-Arcobé L, Benavent D, Valencia-Muntalà L, Gómez-Vaquero C, Juanola X, Nolla JM. Assessing Sarcopenia, Presarcopenia, and Malnutrition in Axial Spondyloarthritis: Insights from a Spanish Cohort. Nutrients. 2025. doi:10.3390/nu17061019
BibTeX
@article{BerbelArcob2025,
author = {Berbel-Arcobé, Laura and Benavent, Diego and Valencia-Muntalà, Lidia and Gómez-Vaquero, Carmen and Juanola, Xavier and Nolla, Joan M},
title = {Assessing Sarcopenia, Presarcopenia, and Malnutrition in Axial Spondyloarthritis: Insights from a Spanish Cohort},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17061019}
}
EUVIMED